Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women

• المؤلفون الرئيسيون: Alice Stek, Brookie M. Best, Jiajia Wang, Edmund V. Capparelli, Sandra K. Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Tim R. Cressey, Lynne M. Mofenson, Elizabeth Smith, David Shapiro, Mark Mirochnick
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84939797350&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/54812

© 2015 Wolters Kluwer Health, Inc. Objective: To describe darunavir (DRV) pharmacokinetics with once-and twice-daily dosing during pregnancy and postpartum in HIV-infected women. Design: Women were enrolled in International Maternal Pediatric Adolescent AIDS Clinical Trials Network Protocol P1026s,...